The early effect of intravenous Digoxin was observed in 12 patients with cardiac enlargement in whom there was no clinical or physiologic evidence of failure. There was either a fall or no change in the cardiac output and the intracardiac pressures did not alter following administration of the drug. The reaction to Digoxin in this type of patient with heart disease was in no way different from the response seen in two normal subjects included in the study but is in sharp contrast to the response elicited in patients in congestive heart failure. P REVIOUS reports have been published on the effects of intravenous Digoxin in left ventricular failure' and iight heart failure2 and these studies have indicated that the failing heart responds with an increase in cardiac output. This effect has been attributed to a myocardial action of the drug. The present study has been undertaken to determine the drug action in patients with enlarged, and hence abnormal, hearts who had no evidence, either clinical or physiologic, of congestive cardiac failure. In considering the esults, interest has been centered about. twno main problems; first, how does the reaction of the enlarged heart to acute digitalization differ from that of the enlarged and decoInpensated heart and second, what information can be obtained about the circulatory dynamics in the former group of patients. The reaction to D)igoxin in 2 individuals without any evi(lence of heart disease is included in this study for comparison, as is the effect of the drug in one patient in congestive failure.
The early effect of intravenous Digoxin was observed in 12 patients with cardiac enlargement in whom there was no clinical or physiologic evidence of failure. There was either a fall or no change in the cardiac output and the intracardiac pressures did not alter following administration of the drug. The reaction to Digoxin in this type of patient with heart disease was in no way different from the response seen in two normal subjects included in the study but is in sharp contrast to the response elicited in patients in congestive heart failure. P REVIOUS reports have been published on the effects of intravenous Digoxin in left ventricular failure' and iight heart failure2 and these studies have indicated that the failing heart responds with an increase in cardiac output. This effect has been attributed to a myocardial action of the drug. The present study has been undertaken to determine the drug action in patients with enlarged, and hence abnormal, hearts who had no evidence, either clinical or physiologic, of congestive cardiac failure. In considering the esults, interest has been centered about. twno main problems; first, how does the reaction of the enlarged heart to acute digitalization differ from that of the enlarged and decoInpensated heart and second, what information can be obtained about the circulatory dynamics in the former group of patients. The reaction to D)igoxin in 2 individuals without any evi(lence of heart disease is included in this study for comparison, as is the effect of the drug in one patient in congestive failure. The work described in this paper was supported by, a grant from the Life Insurance Medical Research Fund, with additional support provided b)y the Commonwealth Fund. 366 MATERIAL AND METHODS The 12 patients with enlarged hearts include 2 with hypertensive cardiovascular disease, 5 with arteriosclerotic heart disease, one with syphilitic and 3 with rheumatic heart disease, and one with an unknown variety of heart disease. The criteria used for diagnosis were these of the New York Heart Association. The functional and therapeutic classification represents the status of the patient at the time of the study. The details of the diagnoses can be found in table 1. It should be noted that 3 of the 12 patients had had a recent episode of cardiac failure. In 2 this appeared to be left heart decanipensation (cases 391 and 418) while in the third patient (case 552) there were signs of right-sided failure as well as of pulmonary congestion. In all 3 however, these signs and symptoms had entirely disappeared after bed rest and without specific medication.
Cardiac enlargement wd-as present in all 12 patients as revealed by x-ray and fluoroscopic examination. However, in 4 of these patients (cases 399, 391, 522, 407) the enlargement was minimal. All but 3 patients (cases 399, 391, 522) had abnormal electrocardiograms.
The method of investigation used in this study has been previously described.' 2 The dosage of D)igoxin varied from 1.00 to 1.50 mg. as can be seen in table 1. In the interpretation of results reference is made to the criteria obtained from control data as presented in a previous publication.' It is well to reiterate that any cardiac output change greater than 9 per cent of the control measurement is ascribed to the action of the drug provided that the oxygen consumption remained constant. Preservation of the steady state is essential in any investigation utilizing the Fick principle. Not only will a constantly changing state invalidate the cardiac HARVEY, FERRER, CATHCART AND ALEXAN AND R3R output measurement but it will obviously provide confusing and conflicting results. Inspection of oxygen consumption measurements and the respiratory quotients throughout the study affords one of the best criteria for the determination of the presence or absence of a steady state and the values for these measurements are essential in evaluating any results.
Changes in the blood pressures were considered significant only if they fell outside a range of variation which has been previously established for this type of investigation'; the values are as follows: for systemic artery blood pressures, sy stolic -16 to +29, diastolic -6 to +13, mean -12 to +18 mm.
Hg; for pulmonary artery, systolic -4 to +5, diastolic -4 to +1, mean ±5 mm. Hg; and for right ventricular end diastolic and right aurieular mean pressures -2 to ±-4 mm. Hg.
RESULTS
The first of the 2 patients with hypertensive heart disease (case 399, in tables 1 and 2) had a normal control cardiac output, right auricular mean pressure and blood volume. The second patient (case 391) had normal right ventricular pressures and a somewhat increased cardiac output (tables 1 and 2). Both patients had a considerable fall in cardiac output after Digoxin, a maximum decrease of 32 per cent and 21 per cent respectively, and a decrease in stroke volume (-37 per cent and -14 per cent), without alteration in the brachial artery or right heart pressures. The heart rate increased in one (case 399) and did not change in the other..
Of the 5 patients (tables I and 2) with arteriosclerotic heart disease, only one had a normal control cardiac output (case 449). Three had low cardiac outputs (cases 402, 444, 418) and only one of these (case 418) had ever been in overt cardiac failure. The fifth patient (case 482) had a systemic blood flow which was at the lower limit of normal. Right heart pressures in all but one patient (case 444) were normal. The latter had pulmonary artery hypertension secondary to chronic pulmonary disease, and a normal right ventricular end diastolic pressure. The systemic blood pressure values were not remarkable. Blood volume measurements were normal in all but 2 of these 5 patients. Increase in the plasma volume was found in the one subject who had been in previous cardiac failure (case 418), and the patient also had a mild anemia (11.5 Gm. hemoglobin). Increase in plasma volume and some increase in red cell volume was noted in the patient (case 444) who had chronic pulmonary disease in addition to heart disease.
The changes in cardiac output following Digoxin were less striking in these 5 patients with arteriosclerotic heart disease than in the 2 with hypertensive heart disease. Three of the 5 had no change in output and in the other 2 (cases 402, 449) the fall was minimal (10 per cent), and even transitory (case 402). Changes in stroke volume appeared equivocal. Only one of these 5 patients had a change in heart rate, a fall of 10 beats. Uniformly there was no alteration in right heart pressures in the entire group. In 2 patients (cases 449, 482) the brachial artery pressures did not vary significantly after Digoxin. A third subject (case 402) had a very marked rise in systolic, diastolic and mean arterial pressures after the drug. In the remaining 2 patients (cases 444, 418) in this group there was a small increase in systolic brachial artery pressure which, however, was probably not significant.
The group of 4 patients With valvular heart disease (cases 429, 498, 522, 552), one of whom (case 429) also had moderate anemia (5.2 Gm. hemoglobin), are also included in tables 1 and 2. The control data reveal that the patient with syphilitic heart disease and anemia (case 429) had an increased cardiac output and plasma volume with normal pulmonary artery and right Ventricular pressures. The brachial artery diastolic pressure was quite low, as might be expected with aortic insufficiency. The other patient with aortic insufficiency, chronic alcoholism, and no anemia (case 498) had a normal cardiac output and an increased plasma voluime. Right heart pressures were normal and there was a low diastolic pressure in the brachial artery. Neither patient had ever shown clinical evidence of cardiac failure. The first patient (case 429) had a 9 per cent decrease in cardiac output after Digoxin, which cannot be considered significant according to the given criteria. This occurred without any other hemodynamic change except for a slight slowing of the heart rate. The patient with rheumatic aortic insufficiency (case 498) had an increase of 18 per cent in cardiac output and 28 per 36/7 cent in stroke volume after the drug. The pulmonary artery and right ventricular pressures did not change, while there was a moderate rise in systolic pressure in the brachial artery. Heart rate did not change significantly.
The data in the rheumatic cardiac patients with mitral valve lesions were of considerable interest. The patient (case 522) with a double mitral lesion and aortic insufficiency had never had any cardiac symptoms. His cardiac output was increased and pulmonary artery, right ventricular and brachial artery pressures were all normal. After administration of Digoxin, there was an equivocal fall (9 per cent) in cardiac output and no other hemodynamic change. The patient (case 552) with only mitral stenosis had recovered from a recent episode of failure. His control cardiac output was quite low and the diastolic and mean pressures in the pulmonary artery were definitely elevated although the systolic was at the upper limit of normal. This pressure pattern probably is the result of some left auricular hypertension secondary to mechanical block at the mitral valve. The brachial artery pressures were somewhat low, as might be expected with the very low stroke volume. The blood volume was normal, as was the end diastolic or filling pressure in the right ventricle. After Digoxin there was no significant change in any of the physiologic measurements made. In the last of the 12 patients with an enlarged heart and no failure (case 407), no etiologic diagnosis could be reached. The electrocardiogram showed T wave abnormalities in leads I and II and V4 through V6, and there was prolongation of the Q-T interval. An elevation of the cardiac output with normal right ventricular and brachial artery pressures and a normal blood volume characterized the control data. After the drug was given the cardiac output fell consistently throughout the post-Digoxin period of 61 minutes, reaching a maximum decrease of 34 per cent. There was a stroke volume fall of 36 per cent at this time, and no change in heart rate. The right auricular and ventricular pressures did not change significantly, but the systemic arterial pressures rose after Digoxin.
In summary, 5 of the 12 patients with enlarged hearts had a fall in cardiac output after Digoxin, in 6 the output did not vary significantly, and in one there was a rise in output. There was no change in right auricular, right ventricular or pulmonary artery pressures in any patient and in only 3 patients was there a significant rise in systemic arterial pressures. Heart rate showed no change in 9 patients and varied only slightly in the other 3.
The 2 subjects with normal hearts (tables 2 and 3) both responded to the administration of Digoxin in the same manner; namely, a fall of 17 per cent and 18 per cent respectively in cardiac output without change in right heart or systemic artery pressures. The heart rate did not alter significantly. The control cardiac output in one of these subjects (case 481) was below the normal range. Such values have occasionally been seen in normal individuals.3 In the absence of any other evidence of circulatory disease this low value is accepted as a normal variant. 
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DISCUSSION
The physiologic findings in the subjects with enlarged hearts confirmed the clinical impression that there was no associated congestive heart failure in any of the 12 patients. Despite a wide variety of clinical diagnoses, they were all strikingly similar in one respect; their pulmonary artery and right ventricular pressures did not indicate failure of emptying of either ventricle. This was obvious in the 10 patients who had normal right heart pressures. In the remaining 2 patients, mild pulmonary hypertension was due in one instance to mechanical block at the mitral valve,4 and in the other to a reduction of the pulmonary vascular bed as a result of chronic pulmonary emphysema.2' If pulmonary hypertension were due to left heart failure in either of these 2 patients, it would have been expected to diminish with Digoxin. Since there was no change in pulmonary artery pressures with acute digitalization, and furthermore in the patient with rheumatic heart disease (case 552) no change in these values was noted after two weeks more of bed rest and maintenance Digoxin, one presumes that in these 2 patients the pulmonary hypertension was due to anatomic lesions.
The level of cardiac output in these 12 patients varied from high to low and apparently had no influence on the pressure pattern at rest. Four of these patients had an increased plasma volume which in 2 was apparently related to anemia, while in the other 2, there was no definite explanation for this mild hypervolemia. However, it is particularly noteworthy that the patients with low cardiac outputs did not necessarily have an increased blood volume.
It should be recalled from previous studies' that when left heart failure is present there is pulmonary artery hypertension which subsides when acute digitalization causes a rise in cardiac output. In right failure an elevated right ventricular diastolic pressure is found and this also is reduced as the output increases with Digoxin intravenously.2 An increase in cardiac output is also the characteristic response to digitalization when either right or left congestive heart failure, or both, exist. This fact is illustrated in figure 1 , which demonstrates graphically the effects of Digoxin in congestive failure in a patient with hypertensive cardiovascular disease. As the output increased the elevated pulmonary artery and right ventricular who received Digoxin. All but one of the patients given Digoxin in this study either had a fall or no change in cardiac output after the drug. Furthermore, there was no effect by Digoxin on the right heart pressures in these 12 cardiac patients or in the 2 patients with normal hearts. It will be recalled from a previous It is obvious that with the exception of one patient (case 498) the reaction to acute digitalization in these patients with enlarged hearts and no failure (see fig. 2 ) differs entirely from the patients in heart failure previously reported and is in no way different or distinct from the reaction of the 2 patients with normal hearts publication2 that Digoxin did not alter cardiac output or right heart pressures in 3 patients with chronic cor pulmonale who had no evidence of heart failure when they received the drug. Hence the absence of effect upon pulmonary artery or right ventricle pressures in a total of 15 patients who were not in cardiac failure would appear to be uniform and conclusive. The variable effect of Digoxin upon the arterial blood pressure has been noted in previous studies.' 9 It can be said that in the present group of patients the changes in blood pressure when they occurred were not primarily de-
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of the other 2, one had a fall and one a rise in systemic blood flow. These data further confirm the impression that the drug has a vasoconstrictor effect on the arteries or arterioles themselves, an action quite separate from the myocardial effect. The action of digitalis preparations upon the compensated but abnormal heart6 as whell as the normal heart'-' has been reported and discussed for many years, and either a fall or no The normal mean values are plotted in the first vertical column. Note (1) the increase in stroke volume and cardiac output accompanied by a fall to normal of the elevated pulmonary artery and right ventricular pressures following administration of the drug, (2) the brachial artery pulse pressure increase. pendent upon cardiac output or stroke volume alterations, since 2 (cases 399, 391) of the 3 patients with the largest fall in cardiac output and stroke volume had no change in systemic blood pressure while in the third (case 407) arterial pressures rose. This patient (case 407) was one of the 3 NXote that the only significant hemody n.rnic change following administration of the drug was a 10 per cent fall in cardiac output. change in cardiac output has been found. It is now possible to measure intracardiac pressures along with the systemic blood flow. From the present study it is evident that in these patients without failure Digoxin does not alter the pulmonary artery pressures, the end diastolic pressure in the right ventricle or the right auricular or central venous pressure. These observations suggest either that there is no peripheral v-enous action of the drug, or that if there is such an effect by this cardiac glycoside it is too small to be detected, or is obscured by rapid reflex venous adjustments, or does not influen(e cen- It is probably impossible as yet, to determine the exact and intimate details of the action of Digoxin in these patients. The solution to this pharmacologic problem will probably come when the whole problem of the metabolism of cardiac muscle is understood. It is foreshadowed, however, in recent reports on the energy mechanism of heart muscle contrac-tionl0-12 which stress the fact that in normal hearts "successive liberation of energy is made possible by expelling electrons from the metabolites via a long series of respiratory enzymes, among which are the cytochromes."'10 In heart failure the muscle metabolism is probably gravely disturbed, and although energy production and oxygen extraction may be normal, energy liberation is impaired. The digitalis bodies have been suggested as substituting for some cardiac enzyme or hormone present in subnormal concentration in heart failure, and thus improving energy liberation and mechanical contraction. The assumption that these drugs do act on some enzymatic system in heart muscle which takes part directly in the contraction and relaxation process is strengthened by recent observations made on the effect of a cardiac glycoside on the contractile proteins myosin and actin.it It has been suggested that these two proteins represent the fundamental constituents of the contractile system of muscle fibers. During contraction they migrate together and form actomyosin which is the working unit for contraction; the energy for the system is supplied by adenosine triphosphate. Snellmanll states that one of the cardiac glycosides (digitotal) has an action upon isolated actin and others" have shown it to have an activating effect upon myosin which suggests that these drugs may directly affect basic enzymatic reactions essential to cardiac muscle contraction. It may well be that cardiac muscle metabolism in these patients with enlarged but compensated hearts differs basically from the metabolism in failing hearts.
Certain of the data in these 12 patients with compensated heart disease provide pertinent information concerning hemodynamics in cardiovascular disease. In 2 patients (case 402, 444) who gave no history suggestive of cardiac insufficiency the resting cardiac output was low. This fact strengthens the concept14 that the absolute level of cardiac output is of less importance in the problem of congestive failure than pressure elevations. In addition the finding of normal pulmonary artery and right ventricular pressures was strikingly consistent in 10 of these patients despite a considerable variation in heart size, basic rhythm and etiologic cause for their cardiac disease. It is well to remember, however, that hearts with low output, not in congestive failure, are nonetheless abnormal and may represent a different aspect of "cardiac failure. " This study, although it clearly demonstrates the difference in reaction to acute digitalization in patients with and without heart failure, does not conclusively answer the question of the usefulness of prophylactic digitalization. It is evident that in the absence of failure Digoxin did not increase the cardiac output, except in one patient, and produced a decrease in 5. However, studies of the reaction of such patients to exercise, before and after digitalization, may provide a more conclusive solution to the problem than will any interpretation of the significance of the cardiac output fall here reported. Such studies are being undertaken at present. SUMMARY AND CONCLUSIONS 1. The early effect of intravenous Digoxin was studied by the cardiac catheterization procedure in 12 patients with enlarged hearts who had no evidence of cardiac failure.
2. In 5 of the 12 patients the cardiac output fell, in 6 the output did not vary, and in one there was a rise.
3. Trhere was no change in right auricular, right ventricular or pulmonary artery pressures in any patient and in only 3 patients was there a significant rise in systemic arterial pressures.
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4. Two patients with normal hearts were also studied and showed a fall in systemic flow after Digoxin. 5. The reaction to Digoxin of the patients with enlarged but nonfailing hearts is contrasted to the response of patients in heart failure.
